Skip to main content
Livermore
Livermore
ZHEN

ObsEva SA

OBSVDelisted Mar 27, 2023
Industry
Pharmaceutical Preparations
SEC CIK
0001685316

ObsEva SA was delisted on Mar 27, 2023; its insiders filed their last Form 4 on Apr 11, 2023; 27 institutions reported holding it in 13F filings for Q4 2022, worth $1.89M in total; no superinvestor held it.

Q2 2022 vs. Q1 2022

How the institutions holding ObsEva SA changed between Q1 2022 and Q2 2022.

All holders in Q2 2022All holders in Q1 2022

13F holders of OBSV: Q1 2022 compared with Q2 2022
MeasureQ1 2022Of which not filed for Q2 2022Q2 2022Change
Holders39240+3
Shares16.1M126.7K15.9M−116.8K (−0.7%)
Value$24.3M$191.0K$25.5M+$1.41M (+5.8%)

2 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.

New holders (7)

Institutions that held ObsEva SA at the end of Q2 2022 but not at the end of Q1 2022.

Institutions new to OBSV in Q2 2022
InstitutionSharesValue% of portfolio
Millennium Management LLC119,537$192.0K0.00%
Susquehanna International Group Ltd.21,395$34.0K0.01%
Laurel Wealth Advisors LLC6,500$10.0K0.00%
BNP Paribas Arbitrage, SA4,076$6.56K0.00%
Royal Bank of Canada1$00.00%
Evoke Wealth, LLC33$00.00%
HighMark Wealth Management LLC200$00.00%

Sold out (4)

Institutions that held ObsEva SA at the end of Q1 2022 and filed for Q2 2022 without it.

Institutions that sold out of OBSV in Q2 2022
InstitutionShares, Q1 2022Value, Q1 2022
Aisling Capital Management LP394,838$596.0K
XTX Topco Ltd79,757$120.0K
Banque Pictet & Cie SA55,000$83.0K
Citadel Advisors LLC21,531$33.0K

Not filed for Q2 2022 yet (2)

Institutions that held ObsEva SA at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding OBSV in Q1 2022 that haven't filed for Q2 2022
InstitutionShares, Q1 2022Value, Q1 2022
Susquehanna Fundamental Investments, LLC115,200$174.0K
Clark Financial Services Group Inc11,500$17.0K